r 2018 b programming language Search Results


incucyte 2018b software  (Sartorius AG)
99
Sartorius AG incucyte 2018b software
Incucyte 2018b Software, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/incucyte 2018b software/product/Sartorius AG
Average 99 stars, based on 1 article reviews
incucyte 2018b software - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier
originpro version 2018b  (OriginLab corp)
90
OriginLab corp originpro version 2018b
Originpro Version 2018b, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/originpro version 2018b/product/OriginLab corp
Average 90 stars, based on 1 article reviews
originpro version 2018b - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
ceftriaxone  (Clinical and Laboratory Standards Institute)
90
Clinical and Laboratory Standards Institute ceftriaxone
Treatment of foreign-body osteomyelitis caused by S. aureus IDRL-4284. *Denotes significance compared to control, ** denotes significance compared to 200 μA alone, *** denotes significance compared to <t>ceftriaxone</t> alone, p<0.05.
Ceftriaxone, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ceftriaxone/product/Clinical and Laboratory Standards Institute
Average 90 stars, based on 1 article reviews
ceftriaxone - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
optimization toolbox release 2018b  (MathWorks Inc)
96
MathWorks Inc optimization toolbox release 2018b
Treatment of foreign-body osteomyelitis caused by S. aureus IDRL-4284. *Denotes significance compared to control, ** denotes significance compared to 200 μA alone, *** denotes significance compared to <t>ceftriaxone</t> alone, p<0.05.
Optimization Toolbox Release 2018b, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/optimization toolbox release 2018b/product/MathWorks Inc
Average 96 stars, based on 1 article reviews
optimization toolbox release 2018b - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
matlab statistics toolbox  (MathWorks Inc)
96
MathWorks Inc matlab statistics toolbox
Treatment of foreign-body osteomyelitis caused by S. aureus IDRL-4284. *Denotes significance compared to control, ** denotes significance compared to 200 μA alone, *** denotes significance compared to <t>ceftriaxone</t> alone, p<0.05.
Matlab Statistics Toolbox, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/matlab statistics toolbox/product/MathWorks Inc
Average 96 stars, based on 1 article reviews
matlab statistics toolbox - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
2018b deep learning toolbox  (MathWorks Inc)
96
MathWorks Inc 2018b deep learning toolbox
Treatment of foreign-body osteomyelitis caused by S. aureus IDRL-4284. *Denotes significance compared to control, ** denotes significance compared to 200 μA alone, *** denotes significance compared to <t>ceftriaxone</t> alone, p<0.05.
2018b Deep Learning Toolbox, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2018b deep learning toolbox/product/MathWorks Inc
Average 96 stars, based on 1 article reviews
2018b deep learning toolbox - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
b adolescentis dsmz 20083  (DSMZ)
95
DSMZ b adolescentis dsmz 20083
Treatment of foreign-body osteomyelitis caused by S. aureus IDRL-4284. *Denotes significance compared to control, ** denotes significance compared to 200 μA alone, *** denotes significance compared to <t>ceftriaxone</t> alone, p<0.05.
B Adolescentis Dsmz 20083, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b adolescentis dsmz 20083/product/DSMZ
Average 95 stars, based on 1 article reviews
b adolescentis dsmz 20083 - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
waste treatment plants and industry  (HELCOM PLC)
90
HELCOM PLC waste treatment plants and industry
Treatment of foreign-body osteomyelitis caused by S. aureus IDRL-4284. *Denotes significance compared to control, ** denotes significance compared to 200 μA alone, *** denotes significance compared to <t>ceftriaxone</t> alone, p<0.05.
Waste Treatment Plants And Industry, supplied by HELCOM PLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/waste treatment plants and industry/product/HELCOM PLC
Average 90 stars, based on 1 article reviews
waste treatment plants and industry - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
b bifidum  (DSMZ)
95
DSMZ b bifidum
Fig. 2 Developmental differences in gut microbial diversity and composition between infants at elevated- and low-likelihood of ASD. a Infants at elevated-likelihood of ASD showed higher alpha diversity during the first year of life, but lower diversity thereafter compared to the low-likelihood group. Dots represent mean estimate per group and whiskers show standard errors. b At 5 months of age, the low- likelihood group presented more Bifidobacterium species (B. breve, B. Bifidum, B. Longum, and B. kashiwanohense), while the elevated-likelihood group harbored more Clostridium related species (C. clostridioforme, C. neonatale, C. difficile, and C. bolteae), B. producta, R. gnavus, and K. variicola. Positive effect sizes indicate higher abundance in the low-likelihood group, while negative effect sizes indicate a greater presence of the taxon in the elevated-likelihood group. Displayed OTUs have p < 0.05 and a circle stroke indicates if the adjusted p value was <0.25. c At 36 months of age, none of the OTUs had an adjusted p value < 0.25, but several species that were more abundant in the low-likelihood group (A. senegalensis, A, timonensis, and I. butyriciproducens), as well as different Bacteroides species that were more abundant in the elevated- likelihood group had absolute effect sizes >0.5. d At 5 months of age, infants at elevated-likelihood of ASD presented significantly less Bifidobacterium, and more Clostridioides and Clostridium compared to infants at low-likelihood of autism. e At 5 months of age, infants at elevated-likelihood of autism had a significantly lower Bifidobacterium/Clostridium ratio compared to the low likelihood one. Boxplots (d, e) represent first (lower), median and third (upper) quartile. Wilcoxon test: *p < 0.05, **p < 0.01. ELCS Early Learning Composite Scores, EL elevated-likelihood, LL low-likelihood.
B Bifidum, supplied by DSMZ, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b bifidum/product/DSMZ
Average 95 stars, based on 1 article reviews
b bifidum - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
capillary column packed (nitroterephthalic acid-modified polyethylene glycol)  (Varian Medical)
90
Varian Medical capillary column packed (nitroterephthalic acid-modified polyethylene glycol)
Fig. 2 Developmental differences in gut microbial diversity and composition between infants at elevated- and low-likelihood of ASD. a Infants at elevated-likelihood of ASD showed higher alpha diversity during the first year of life, but lower diversity thereafter compared to the low-likelihood group. Dots represent mean estimate per group and whiskers show standard errors. b At 5 months of age, the low- likelihood group presented more Bifidobacterium species (B. breve, B. Bifidum, B. Longum, and B. kashiwanohense), while the elevated-likelihood group harbored more Clostridium related species (C. clostridioforme, C. neonatale, C. difficile, and C. bolteae), B. producta, R. gnavus, and K. variicola. Positive effect sizes indicate higher abundance in the low-likelihood group, while negative effect sizes indicate a greater presence of the taxon in the elevated-likelihood group. Displayed OTUs have p < 0.05 and a circle stroke indicates if the adjusted p value was <0.25. c At 36 months of age, none of the OTUs had an adjusted p value < 0.25, but several species that were more abundant in the low-likelihood group (A. senegalensis, A, timonensis, and I. butyriciproducens), as well as different Bacteroides species that were more abundant in the elevated- likelihood group had absolute effect sizes >0.5. d At 5 months of age, infants at elevated-likelihood of ASD presented significantly less Bifidobacterium, and more Clostridioides and Clostridium compared to infants at low-likelihood of autism. e At 5 months of age, infants at elevated-likelihood of autism had a significantly lower Bifidobacterium/Clostridium ratio compared to the low likelihood one. Boxplots (d, e) represent first (lower), median and third (upper) quartile. Wilcoxon test: *p < 0.05, **p < 0.01. ELCS Early Learning Composite Scores, EL elevated-likelihood, LL low-likelihood.
Capillary Column Packed (Nitroterephthalic Acid Modified Polyethylene Glycol), supplied by Varian Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/capillary column packed (nitroterephthalic acid-modified polyethylene glycol)/product/Varian Medical
Average 90 stars, based on 1 article reviews
capillary column packed (nitroterephthalic acid-modified polyethylene glycol) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
graphpad prism 8.0  (GraphPad Software Inc)
90
GraphPad Software Inc graphpad prism 8.0
Fig. 2 Developmental differences in gut microbial diversity and composition between infants at elevated- and low-likelihood of ASD. a Infants at elevated-likelihood of ASD showed higher alpha diversity during the first year of life, but lower diversity thereafter compared to the low-likelihood group. Dots represent mean estimate per group and whiskers show standard errors. b At 5 months of age, the low- likelihood group presented more Bifidobacterium species (B. breve, B. Bifidum, B. Longum, and B. kashiwanohense), while the elevated-likelihood group harbored more Clostridium related species (C. clostridioforme, C. neonatale, C. difficile, and C. bolteae), B. producta, R. gnavus, and K. variicola. Positive effect sizes indicate higher abundance in the low-likelihood group, while negative effect sizes indicate a greater presence of the taxon in the elevated-likelihood group. Displayed OTUs have p < 0.05 and a circle stroke indicates if the adjusted p value was <0.25. c At 36 months of age, none of the OTUs had an adjusted p value < 0.25, but several species that were more abundant in the low-likelihood group (A. senegalensis, A, timonensis, and I. butyriciproducens), as well as different Bacteroides species that were more abundant in the elevated- likelihood group had absolute effect sizes >0.5. d At 5 months of age, infants at elevated-likelihood of ASD presented significantly less Bifidobacterium, and more Clostridioides and Clostridium compared to infants at low-likelihood of autism. e At 5 months of age, infants at elevated-likelihood of autism had a significantly lower Bifidobacterium/Clostridium ratio compared to the low likelihood one. Boxplots (d, e) represent first (lower), median and third (upper) quartile. Wilcoxon test: *p < 0.05, **p < 0.01. ELCS Early Learning Composite Scores, EL elevated-likelihood, LL low-likelihood.
Graphpad Prism 8.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/graphpad prism 8.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
graphpad prism 8.0 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
environmental quality standard eqs  (HELCOM PLC)
90
HELCOM PLC environmental quality standard eqs
Fig. 2 Developmental differences in gut microbial diversity and composition between infants at elevated- and low-likelihood of ASD. a Infants at elevated-likelihood of ASD showed higher alpha diversity during the first year of life, but lower diversity thereafter compared to the low-likelihood group. Dots represent mean estimate per group and whiskers show standard errors. b At 5 months of age, the low- likelihood group presented more Bifidobacterium species (B. breve, B. Bifidum, B. Longum, and B. kashiwanohense), while the elevated-likelihood group harbored more Clostridium related species (C. clostridioforme, C. neonatale, C. difficile, and C. bolteae), B. producta, R. gnavus, and K. variicola. Positive effect sizes indicate higher abundance in the low-likelihood group, while negative effect sizes indicate a greater presence of the taxon in the elevated-likelihood group. Displayed OTUs have p < 0.05 and a circle stroke indicates if the adjusted p value was <0.25. c At 36 months of age, none of the OTUs had an adjusted p value < 0.25, but several species that were more abundant in the low-likelihood group (A. senegalensis, A, timonensis, and I. butyriciproducens), as well as different Bacteroides species that were more abundant in the elevated- likelihood group had absolute effect sizes >0.5. d At 5 months of age, infants at elevated-likelihood of ASD presented significantly less Bifidobacterium, and more Clostridioides and Clostridium compared to infants at low-likelihood of autism. e At 5 months of age, infants at elevated-likelihood of autism had a significantly lower Bifidobacterium/Clostridium ratio compared to the low likelihood one. Boxplots (d, e) represent first (lower), median and third (upper) quartile. Wilcoxon test: *p < 0.05, **p < 0.01. ELCS Early Learning Composite Scores, EL elevated-likelihood, LL low-likelihood.
Environmental Quality Standard Eqs, supplied by HELCOM PLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/environmental quality standard eqs/product/HELCOM PLC
Average 90 stars, based on 1 article reviews
environmental quality standard eqs - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Treatment of foreign-body osteomyelitis caused by S. aureus IDRL-4284. *Denotes significance compared to control, ** denotes significance compared to 200 μA alone, *** denotes significance compared to ceftriaxone alone, p<0.05.

Journal: Diagnostic microbiology and infectious disease

Article Title: Activity of Fixed Direct Electrical Current in Experimental Staphylococcus aureus Foreign Body Osteomyelitis

doi: 10.1016/j.diagmicrobio.2018.09.006

Figure Lengend Snippet: Treatment of foreign-body osteomyelitis caused by S. aureus IDRL-4284. *Denotes significance compared to control, ** denotes significance compared to 200 μA alone, *** denotes significance compared to ceftriaxone alone, p<0.05.

Article Snippet: Susceptibility to oxacillin and cefoxitin infers susceptibility to ceftriaxone ( Clinical and Laboratory Standards Institute, 2018a , 2018b ).

Techniques: Control

Fig. 2 Developmental differences in gut microbial diversity and composition between infants at elevated- and low-likelihood of ASD. a Infants at elevated-likelihood of ASD showed higher alpha diversity during the first year of life, but lower diversity thereafter compared to the low-likelihood group. Dots represent mean estimate per group and whiskers show standard errors. b At 5 months of age, the low- likelihood group presented more Bifidobacterium species (B. breve, B. Bifidum, B. Longum, and B. kashiwanohense), while the elevated-likelihood group harbored more Clostridium related species (C. clostridioforme, C. neonatale, C. difficile, and C. bolteae), B. producta, R. gnavus, and K. variicola. Positive effect sizes indicate higher abundance in the low-likelihood group, while negative effect sizes indicate a greater presence of the taxon in the elevated-likelihood group. Displayed OTUs have p < 0.05 and a circle stroke indicates if the adjusted p value was <0.25. c At 36 months of age, none of the OTUs had an adjusted p value < 0.25, but several species that were more abundant in the low-likelihood group (A. senegalensis, A, timonensis, and I. butyriciproducens), as well as different Bacteroides species that were more abundant in the elevated- likelihood group had absolute effect sizes >0.5. d At 5 months of age, infants at elevated-likelihood of ASD presented significantly less Bifidobacterium, and more Clostridioides and Clostridium compared to infants at low-likelihood of autism. e At 5 months of age, infants at elevated-likelihood of autism had a significantly lower Bifidobacterium/Clostridium ratio compared to the low likelihood one. Boxplots (d, e) represent first (lower), median and third (upper) quartile. Wilcoxon test: *p < 0.05, **p < 0.01. ELCS Early Learning Composite Scores, EL elevated-likelihood, LL low-likelihood.

Journal: Translational psychiatry

Article Title: Early-life differences in the gut microbiota composition and functionality of infants at elevated likelihood of developing autism spectrum disorder.

doi: 10.1038/s41398-023-02556-6

Figure Lengend Snippet: Fig. 2 Developmental differences in gut microbial diversity and composition between infants at elevated- and low-likelihood of ASD. a Infants at elevated-likelihood of ASD showed higher alpha diversity during the first year of life, but lower diversity thereafter compared to the low-likelihood group. Dots represent mean estimate per group and whiskers show standard errors. b At 5 months of age, the low- likelihood group presented more Bifidobacterium species (B. breve, B. Bifidum, B. Longum, and B. kashiwanohense), while the elevated-likelihood group harbored more Clostridium related species (C. clostridioforme, C. neonatale, C. difficile, and C. bolteae), B. producta, R. gnavus, and K. variicola. Positive effect sizes indicate higher abundance in the low-likelihood group, while negative effect sizes indicate a greater presence of the taxon in the elevated-likelihood group. Displayed OTUs have p < 0.05 and a circle stroke indicates if the adjusted p value was <0.25. c At 36 months of age, none of the OTUs had an adjusted p value < 0.25, but several species that were more abundant in the low-likelihood group (A. senegalensis, A, timonensis, and I. butyriciproducens), as well as different Bacteroides species that were more abundant in the elevated- likelihood group had absolute effect sizes >0.5. d At 5 months of age, infants at elevated-likelihood of ASD presented significantly less Bifidobacterium, and more Clostridioides and Clostridium compared to infants at low-likelihood of autism. e At 5 months of age, infants at elevated-likelihood of autism had a significantly lower Bifidobacterium/Clostridium ratio compared to the low likelihood one. Boxplots (d, e) represent first (lower), median and third (upper) quartile. Wilcoxon test: *p < 0.05, **p < 0.01. ELCS Early Learning Composite Scores, EL elevated-likelihood, LL low-likelihood.

Article Snippet: This included five different Bifidobacterium species, B. breve (DSM20091/ATCC15698), B. bifidum (DSM20215), B. longum subsp. infantis (ATCC17930/DSM20218), B. adolescentis (DSM20083), and B. scardovii (DSM13734), and two Clostridium related species, C. difficile (DSM1296), and C. bolteae (DSM15670) purchased from the DSMZ catalog (Leibniz- Institut DSMZ, Germany).

Techniques: